Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2026-02-03 @ 8:06 AM
Study NCT ID:
NCT01666535
Status:
COMPLETED
Last Update Posted:
2016-05-09
First Post:
2012-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Infliximab IBD Influenza Vaccine Study
Sponsor:
University of Calgary
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
REMICADEIBD4010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |